Lannett Provides Update On Contract Renewal With Jerome Stevens Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Lannett Co (LCI) PT Lowered to 'Street Low' $5 at Deutsche Bank
August 20, 2018 1:46 PM EDTDeutsche Bank analyst Gregg Gilbert lowered the price target on Lannett Co (NYSE: LCI) to a street low $5.00 (from $20.00) while maintaining a Hold rating amid news the contract with Jerome Stevens Pharmaceuticals (JSP) will not be renewed.
"Our new target... More
Craig-Hallum Downgrades Lannett Co (LCI) to Neutral
August 20, 2018 12:57 PM EDTCraig-Hallum analyst Matthew Hewitt downgraded Lannett Co (NYSE: LCI) from Buy to Neutral with a price target of $7.00.
The analyst said the end of the JSP relationship creates a noticeable cash flow void.
For an analyst ratings summary and ratings... More



